Skip to main content

Table 2 Mutation rate for different kind of body fluid samples in our clinical practice using sequencing

From: A comparison of ARMS and direct sequencing for EGFR mutation analysis and Tyrosine Kinase Inhibitors treatment prediction in body fluid samples of Non-Small-Cell Lung Cancer patients

  Pleural fluid Plasma Total
Total 142 78 220
19-del 18 2 20
L858R 15 2 17
Mutation rate (%) 23.2 5.1 16.8